• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α干扰素和β干扰素具有共享的受体成分,但形成不同的复合物。

Shared receptor components but distinct complexes for alpha and beta interferons.

作者信息

Lewerenz M, Mogensen K E, Uzé G

机构信息

Institut de Génétique Moléculaire, CNRS UMR 5535, 1919 Route de Mende, Montpellier Cedex 5, 34293, France.

出版信息

J Mol Biol. 1998 Sep 25;282(3):585-99. doi: 10.1006/jmbi.1998.2026.

DOI:10.1006/jmbi.1998.2026
PMID:9737924
Abstract

The type I interferon family includes 13 alpha, one omega and one beta subtypes recognized by a complex containing the receptor subunits ifnar1 and ifnar2 and their associated Janus tyrosine kinases, Tyk2 and Jak1. To investigate the reported differences in the way that alpha and beta interferons signal through the receptor, we introduced alanine-substitutions in the ifnar2 extracellular domain, and expressed the mutants in U5A cells, lacking endogenous ifnar2. A selection, designed to recover mutants that responded preferentially to alpha or beta interferon yielded three groups: I, neutral; II, sensitive to alpha interferon, partially resistant to beta interferon; III, resistant to alpha interferon, partially sensitive to beta interferon. A mutant clone, TMK, fully resistant to alpha interferon with good sensitivity to beta interferon, was characterized in detail and compared with U5A cells complemented with wild-type ifnar2 and also with Tyk2-deficient 11.1 cells, which exhibit a similar alpha-unresponsive phenotype with a partial beta interferon response. Using anti-receptor antibodies and mutant forms of beta interferon, three distinct modes of ligand interaction could be discerned: (i) alpha interferon with ifnar1 and ifnar2; (ii) beta interferon with ifnar1 and ifnar2; (iii) beta interferon with ifnar2 alone. We conclude that alpha and beta interferons signal differently through their receptors because the two ligand subtypes interact with the receptor subunits ifnar 1 and ifnar2 in entirely different ways.

摘要

I型干扰素家族包括13种α亚型、1种ω亚型和1种β亚型,它们可被一种复合物识别,该复合物包含受体亚基ifnar1和ifnar2以及它们相关的Janus酪氨酸激酶Tyk2和Jak1。为了研究α干扰素和β干扰素通过受体发出信号的方式的报道差异,我们在ifnar2细胞外结构域引入丙氨酸替代,并在缺乏内源性ifnar2的U5A细胞中表达突变体。一种旨在筛选优先对α干扰素或β干扰素作出反应的突变体的筛选方法产生了三组:I组,中性;II组,对α干扰素敏感,对β干扰素部分耐药;III组,对α干扰素耐药,对β干扰素部分敏感。详细表征了一个对α干扰素完全耐药且对β干扰素敏感的突变体克隆TMK,并将其与用野生型ifnar2互补的U5A细胞以及Tyk2缺陷的11.1细胞进行比较,后者表现出类似的α无反应表型和部分β干扰素反应。使用抗受体抗体和β干扰素的突变形式,可以辨别出三种不同的配体相互作用模式:(i)α干扰素与ifnar1和ifnar2;(ii)β干扰素与ifnar1和ifnar2;(iii)β干扰素仅与ifnar2。我们得出结论,α干扰素和β干扰素通过其受体发出信号的方式不同,因为这两种配体亚型以完全不同的方式与受体亚基ifnar1和ifnar2相互作用。

相似文献

1
Shared receptor components but distinct complexes for alpha and beta interferons.α干扰素和β干扰素具有共享的受体成分,但形成不同的复合物。
J Mol Biol. 1998 Sep 25;282(3):585-99. doi: 10.1006/jmbi.1998.2026.
2
Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.鉴定对配体结合和生物活性至关重要的人I型干扰素受体IFNAR1链的残基。
Biochemistry. 2004 Oct 5;43(39):12498-512. doi: 10.1021/bi049111r.
3
Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.I型干扰素与其受体Ifnar2结合界面的突变与结构分析
J Mol Biol. 1999 Nov 19;294(1):223-37. doi: 10.1006/jmbi.1999.3230.
4
Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.I型干扰素受体亚基ifnar1胞外域的功能图谱
J Mol Biol. 2005 Jul 15;350(3):476-88. doi: 10.1016/j.jmb.2005.05.008.
5
Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.人干扰素-β-1a与其受体链形成的可溶性三元复合物的特性分析。
Protein Sci. 1999 Sep;8(9):1867-77. doi: 10.1110/ps.8.9.1867.
6
Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity.干扰素无结构的C末端尾巴的变异会导致不同的受体结合和生物学活性。
J Mol Biol. 2006 Jul 28;360(5):1019-30. doi: 10.1016/j.jmb.2006.05.069. Epub 2006 Jun 15.
7
Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.配体诱导的I型干扰素受体在支持脂质双分子层上的组装。
J Mol Biol. 2004 Jul 30;341(1):303-18. doi: 10.1016/j.jmb.2004.05.059.
8
Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.缺乏酪氨酸激酶2(Tyk2)的细胞中I型杂交干扰素的活性:IFN-α8的一个共同区域可诱导反应,但IFN-α2/8杂交体的表现可能类似IFN-β。
J Interferon Cytokine Res. 2003 Nov;23(11):655-66. doi: 10.1089/107999003322558791.
9
Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.IFNα2和IFNβ在JAK/STAT即刻激活方面具有相当的效力,但在IFNAR2的下调方面存在差异。
Biochem J. 2007 Oct 1;407(1):141-51. doi: 10.1042/BJ20070605.
10
NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.人I型干扰素结合亚基(一种代表性细胞因子受体)的核磁共振主链动力学
Biochemistry. 2004 Aug 10;43(31):10127-37. doi: 10.1021/bi049606g.

引用本文的文献

1
The Cytomegalovirus M35 Protein Directly Binds to the Interferon-β Enhancer and Modulates Transcription of and Other IRF3-Driven Genes.巨细胞病毒 M35 蛋白直接结合干扰素-β增强子并调节 和其他 IRF3 驱动基因的转录。
J Virol. 2023 Jun 29;97(6):e0040023. doi: 10.1128/jvi.00400-23. Epub 2023 Jun 8.
2
The Interferon-Inducible Proteoglycan Testican-2/SPOCK2 Functions as a Protective Barrier against Virus Infection of Lung Epithelial Cells.干扰素诱导的蛋白聚糖 Testican-2/SPOCK2 作为肺上皮细胞抵抗病毒感染的保护屏障发挥作用。
J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.00662-19. Print 2019 Oct 15.
3
Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
Ⅰ型干扰素信号在病毒感染和肿瘤微环境中减弱调节性 T 细胞的功能。
PLoS Pathog. 2018 Apr 19;14(4):e1006985. doi: 10.1371/journal.ppat.1006985. eCollection 2018 Apr.
4
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.不同自身免疫性疾病中IFNα和IFNβ介导的反应程序多样化的生理学证据。
Arthritis Res Ther. 2016 Feb 17;18:49. doi: 10.1186/s13075-016-0946-9.
5
Cytokine Activation by Antibody Fragments Targeted to Cytokine-Receptor Signaling Complexes.靶向细胞因子受体信号复合物的抗体片段激活细胞因子
J Biol Chem. 2016 Jan 1;291(1):447-61. doi: 10.1074/jbc.M115.665943. Epub 2015 Nov 6.
6
Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection.干扰素-α和-β的选择性阻断揭示了它们在西尼罗河病毒感染小鼠模型中的非冗余功能。
PLoS One. 2015 May 26;10(5):e0128636. doi: 10.1371/journal.pone.0128636. eCollection 2015.
7
Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab.全人源抗干扰素单克隆抗体西法昔单抗中和特性的结构见解
J Biol Chem. 2015 Jun 12;290(24):14979-85. doi: 10.1074/jbc.M115.652156. Epub 2015 Apr 29.
8
Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers.采用工程化 FC 异二聚体分析细胞因子介导的受体组装的动力学。
Protein Sci. 2013 Aug;22(8):1100-8. doi: 10.1002/pro.2285. Epub 2013 Jun 6.
9
The interferons and their receptors--distribution and regulation.干扰素及其受体——分布与调节。
Immunol Cell Biol. 2012 May;90(5):483-91. doi: 10.1038/icb.2012.9. Epub 2012 Mar 13.
10
An orally available, small-molecule interferon inhibits viral replication.一种可口服的小分子干扰素可抑制病毒复制。
Sci Rep. 2012;2:259. doi: 10.1038/srep00259. Epub 2012 Feb 10.